Rockwell Medical (RMTI) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

RMTI Stock Forecast


Rockwell Medical (RMTI) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $3.00 and a low of $3.00. This represents a 209.28% increase from the last price of $0.97.

High: $3 Avg: $3 Low: $3 Last Closed Price: $0.97

RMTI Stock Rating


Rockwell Medical stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (71.43%), 2 Hold (14.29%), 2 Sell (14.29%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 2 2 10 Strong Sell Sell Hold Buy Strong Buy

RMTI Price Target Upside V Benchmarks


TypeNameUpside
StockRockwell Medical209.28%
SectorHealthcare Stocks 24.81%
IndustrySpecialty & Generic Drug Manufacturers Stocks29.65%

Price Target Trends


1M3M12M
# Anlaysts-12
Avg Price Target-$3.00$6.00
Last Closing Price$0.97$0.97$0.97
Upside/Downside-209.28%518.56%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 252----2
May, 252----2
Apr, 252----2
Mar, 252----2
Feb, 252----2
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 24, 2025Raghuram SelvarajuH.C. Wainwright$3.00$1.26138.10%209.28%
Sep 04, 2024Raghuram SelvarajuH.C. Wainwright$9.00$3.19182.13%827.84%
Jul 17, 2023Raghuram SelvarajuH.C. Wainwright$11.00$4.19162.53%1034.02%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Mar 24, 2025H.C. WainwrightBuyBuyhold
Sep 04, 2024H.C. WainwrightBuyBuyhold
Jul 17, 2023H.C. WainwrightBuyBuyhold

Financial Forecast


EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-4.64$-4.11$-2.09$-0.36$-0.02----
Avg Forecast$-4.35$-3.74$-2.12$-0.40$0.01$-0.09$-0.07$-0.03$0.06
High Forecast$-4.30$-3.70$-2.06$-0.39$0.01$-0.09$-0.07$-0.03$0.06
Low Forecast$-4.39$-3.78$-2.18$-0.41$0.01$-0.09$-0.07$-0.03$0.06
Surprise %6.67%9.89%-1.42%-10.00%-300.00%----

Revenue Forecast

$60M $69M $78M $87M $96M $105M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$62.20M$61.93M$72.81M$83.61M$101.49M----
Avg Forecast$62.73M$64.25M$69.80M$84.15M$100.32M$77.13M$76.83M$69.40M$74.90M
High Forecast$63.18M$64.72M$71.21M$86.34M$102.93M$79.13M$78.83M$71.20M$76.85M
Low Forecast$62.27M$63.78M$68.39M$81.97M$97.71M$75.12M$74.83M$67.60M$72.95M
Surprise %-0.84%-3.61%4.31%-0.64%1.17%----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-31.93M$-35.03M$-20.58M$-8.44M$-480.00K----
Avg Forecast$-101.34M$-87.23M$-62.32M$-8.59M$233.23K$-2.10M$-1.63M$-699.69K$1.40M
High Forecast$-100.37M$-86.40M$-49.86M$-6.87M$241.11K$-2.03M$-1.58M$-676.04K$1.45M
Low Forecast$-102.30M$-88.06M$-74.79M$-10.31M$225.35K$-2.17M$-1.69M$-723.33K$1.35M
Surprise %-68.49%-59.84%-66.98%-1.75%-305.81%----

RMTI Forecast FAQ


Is Rockwell Medical stock a buy?

Rockwell Medical stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Rockwell Medical is a favorable investment for most analysts.

What is Rockwell Medical's price target?

Rockwell Medical's price target, set by 14 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $3 at the low end to $3 at the high end, suggesting a potential 209.28% change from the previous closing price of $0.97.

How does Rockwell Medical stock forecast compare to its benchmarks?

Rockwell Medical's stock forecast shows a 209.28% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the specialty & generic drug manufacturers stocks industry (29.65%).

What is the breakdown of analyst ratings for Rockwell Medical over the past three months?

  • June 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Rockwell Medical’s EPS forecast?

Rockwell Medical's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.09, marking a 350.00% increase from the reported $-0.02 in 2024. Estimates for the following years are $-0.07 in 2026, $-0.03 in 2027, and $0.06 in 2028.

What is Rockwell Medical’s revenue forecast?

Rockwell Medical's average annual revenue forecast for its fiscal year ending in December 2025 is $77.13M, reflecting a -24.01% decrease from the reported $101.49M in 2024. The forecast for 2026 is $76.83M, followed by $69.4M for 2027, and $74.9M for 2028.

What is Rockwell Medical’s net income forecast?

Rockwell Medical's net income forecast for the fiscal year ending in December 2025 stands at $-2.099M, representing an 337.30% increase from the reported $-480K in 2024. Projections indicate $-1.633M in 2026, $-700K in 2027, and $1.4M in 2028.